- Home
- SGHT vs CEP Comparison
SGHT vs CEP Comparison
Compare SGHT & CEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- CEP
- Stock Information
- Founded
- SGHT 2011
- CEP 2020
- Country
- SGHT United States
- CEP United States
- Employees
- SGHT N/A
- CEP N/A
- Industry
- SGHT Medical Specialities
- CEP
- Sector
- SGHT Health Care
- CEP
- Exchange
- SGHT Nasdaq
- CEP NYSE
- Market Cap
- SGHT 140.1M
- CEP 133.8M
- IPO Year
- SGHT 2021
- CEP 2024
- Fundamental
- Price
- SGHT $2.53
- CEP $10.38
- Analyst Decision
- SGHT Buy
- CEP
- Analyst Count
- SGHT 7
- CEP 0
- Target Price
- SGHT $4.68
- CEP N/A
- AVG Volume (30 Days)
- SGHT 195.9K
- CEP 3.2K
- Earning Date
- SGHT 03-05-2025
- CEP 01-01-0001
- Dividend Yield
- SGHT N/A
- CEP N/A
- EPS Growth
- SGHT N/A
- CEP N/A
- EPS
- SGHT N/A
- CEP 0.06
- Revenue
- SGHT $79,543,000.00
- CEP N/A
- Revenue This Year
- SGHT $1.23
- CEP N/A
- Revenue Next Year
- SGHT $0.34
- CEP N/A
- P/E Ratio
- SGHT N/A
- CEP $187.78
- Revenue Growth
- SGHT N/A
- CEP N/A
- 52 Week Low
- SGHT $2.50
- CEP $9.99
- 52 Week High
- SGHT $8.45
- CEP $10.95
- Technical
- Relative Strength Index (RSI)
- SGHT 35.62
- CEP N/A
- Support Level
- SGHT $2.59
- CEP N/A
- Resistance Level
- SGHT $2.87
- CEP N/A
- Average True Range (ATR)
- SGHT 0.18
- CEP 0.00
- MACD
- SGHT 0.02
- CEP 0.00
- Stochastic Oscillator
- SGHT 6.74
- CEP 0.00
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About CEP CANTOR EQUITY PARTNERS INC
Cantor Equity Partners Inc is a blank check company.